A carregar...
5-HT3 antagonist ondansetron--an effective outpatient antiemetic in cancer treatment.
Thirty children aged 2-16 years with malignant tumours who were receiving chemotherapy were treated with the 5-HT3 antagonist ondansetron. Each received a single intravenous dose (5 mg/m2) followed by oral doses (2-4 mg depending on surface area) every eight hours for five days. Chemotherapy regimen...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
1990
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1792498/ https://ncbi.nlm.nih.gov/pubmed/2144721 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|